It is widely accepted that renal cell carcinoma with liver metastasis carries a dismal prognosis. We aimed to explore the value of cytoreductive nephrectomy among these patients. Patients were extracted from the SEER database between 2010 and 2017. The univariate and multivariate Cox proportional hazards models were conducted to select the prognostic predictors of survival. Patients were divided into nephrectomy and non-nephrectomy groups. Propensity score-matching analyses were applied to reduce the above factors’ differences between the groups. Overall survival was compared by Kaplan-Meier (K-M) analyses. Data from 683 patients was extracted from the database. The univariate Cox regression and multivariate Cox regression revealed that factors including age, histologic type, T and N stages, lung metastasis, brain metastasis, and nephrectomy were significant predictors of survival in the patients. After the propensity score-matching analyses, we found that nephrectomy prolonged overall survival. Nephrectomy can prolong overall survival in eligible renal cell carcinoma patients with liver metastasis.
Background: Benign prostatic hyperplasia (BPH) is a common condition affecting the urinary tract. This study aimed at exploring the potential of Guiyi Tonglong (GYTL) prescription for the treatment of benign prostatic hyperplasia using network pharmacology and molecular docking technology. Methods: The main active ingredients in GYTL prescription were identified from the Traditional Chinese Medicine Systems Pharmacology and the Integrative Pharmacology-based Traditional Chinese Medicine (TCMIP) databases based on drug similarity of ≥ 30% and oral bioavailability of ≥ 0.18. Protein–protein interaction (PPI) networks, gene ontology, and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were used to study the interactions and pathway enrichment and establish ingredient-target-pathway networks. The structure of the active ingredient was docked to that of the potential protein target using the AutoDock molecular docking software. Results: A total of 86 active ingredients and 130 potential targets were screened from GYTL prescription, and a PPI network was constructed to identify the five most important core targets, namely SRC, TP53, STAT3, AKT1, and PIK3CA. Enrichment analysis revealed that GYTL prescription may play a role in the treatment of BPH through multiple signaling pathways, such as PI3K-Akt, EGFR, AGE-RAGE, and HIF-1. Molecular docking indicated a potential interaction between the active ingredients and targets. Conclusion: These results provide further information regarding the active ingredients and molecular mechanisms of GYTL prescription in treating BPH.